Genomic Biomarkers in Cancer

Track 11: Genomic Biomarkers in Cancer:

A biomarker is a quantifiable marker of the severity or presence of some diseased state. Generally biomarker is anything that can be utilized as a pointer of a diseased state or some other physiological condition of an organism. Cell-free, circulating tumor DNA (ctDNA) can act as a noninvasive growth biomarker, offering a potential contrasting option to invasive tissue biopsies. Today, specialists are exploring the utilization of ctDNA as a biomarker for distinguishing the nearness of tumors in different cancer types. Later on, ctDNA could possibly serve as a noninvasive approach for continuous checking of treatment reaction and Identifying candidates for treatment. Tumor-specific genetic and epigenetic changes can be identified in the body liquids of patients with malignancy. This circulating tumor-specific DNA (ctDNA) gives information about the genomic arrangement of cancer. Auto Antibodies are interesting because the immune system senses cancer long before the disease manifests itself in other ways. Hyper methylated ccfDNA is a developing range of interest for cancer diagnostics. Detecting tumor cells circulating (CTC) in the peripheral blood of cancer patients could be a promising strategy for determination and observing gastric cancer

The global biomarkers market was esteemed at USD 23.9 billion in 2015. The expanding utilization of biomarkers for drug discovery and advancement combined with high R&D consumption is a noteworthy pushing element for the market development. This market is relied upon to develop at a CAGR of 11.6% from 2015 to 2020

  • Predisposition Biomarkers
  • Diagnostic Biomarkers
  • Prognostic Biomarkers
  • Predictive Biomarkers
  • Genetic biomarkers
  • Pathological biomarkers
  • In silico biomarkers
  • Imaging biomarkers
  • Glycoprotein biomarkers
  • Identifying and prioritizing biomarkers
  • Circulating biomarkers

Related Conference of Genomic Biomarkers in Cancer

September 18-19, 2017

International Conference on Cancer Biology R&D and Market

Philadelphia, Pennsylvania, USA
June 29-July 01, 2017

International Conference on Hematology and Oncology

Bangkok, Thailand
July 17-19, 2017

19th Euro Congress on Cancer Science and Therapy

Lisbon, Portugal
August 28-30, 2017

Oncologist & Diagnostics Conference

Brussels, Belgium
October 9-10, 2017

Global Meeting on Molecular & Cancer Biomarkers

Dubai, UAE
October 18-20, 2017

25th World Congress on Cancer Science and Therapy

Baltimore, Maryland, USA
October 19-20, 2017

15th World Oncologists Annual Conference

New York ,USA
Oct 19-21, 2017

25th World Cancer Conference

Rome, Italy
October 26-28, 2017

9th International Conference on Biomarkers

Osaka,Japan
November 06-08, 2017

2nd International Congress on Epigenetics & Chromatin

H4 Hotel Frankfurt Messe, Frankfurt, Germany
November 09-10, 2017

10th World Hematology and Oncology Congress

Vienna, Austria
November 16-17, 2017

World Cancer Meeting

Singapore
November 20-22, 2017

14th Asia Pacific
Oncologists Annual Meeting

Melbourne, Australia
November 27-28, 2017

26th World Cancer Convention

Dubai, UAE
November 27- 28, 2017

International Conference on Cancer Diagnostics

Dubai, UAE
December 07-08, 2017

9th World Biomarkers Congress

Madrid, Spain
May 24-25, 2018

22nd Global Annual Oncologists Meeting

Osaka, Japan

Genomic Biomarkers in Cancer Conference Speakers

Recommended Sessions

Related Journals

Are you interested in